Sevika Medical AG

Based in Switzerland, Sevika Medical AG is dedicated to the distribution of advanced orthopedic technologies, enhancing surgical practices for improved patient outcomes through innovative medical solutions. Sevika Medical AG, established in 2010, is headquartered in Baar, Switzerland, focusing on orthopedic solutions. The firm has executed one deal, with its most recent transaction occurring on December 23, 2025, when it was acquired by Healthcare Holding Schweiz AG, part of Winterberg Group and KKA Partners. Sevika Medical AG specializes in the distribution of advanced orthopedic technologies, focusing on innovative solutions that enhance surgical practices and improve patient outcomes.

The company’s core product offerings include navigation and robotics systems for hip and knee surgeries, along with solutions for orthobiology and infection management. Their partnership with NAVISWISS allows them to deliver exclusive hip and knee navigation technologies in Switzerland, directly benefiting orthopedic surgeons. Additionally, Sevika Medical AG markets products for managing prosthetic joint infections, developed in collaboration with Biocomposites, and supports the development of arthroscopic techniques with Pivot Medical. Their client base includes orthopedic surgeons and specialized clinics across Switzerland and select European markets.

Sevika Medical AG generates revenue through strategic partnerships and direct sales of medical solutions to healthcare providers. Operating a business-to-business model, the company provides products directly to hospitals and surgical centers, fostering long-term client relationships. Transactions frequently involve flagship products like ArthroZheal®, a platelets-rich fibrin sealing solution, and navigation technologies for hip and knee surgeries, sold under exclusive agreements that may include service contracts for ongoing support and training. In light of the recent acquisition, Sevika Medical AG is poised for expansion and product innovation.

The company plans to introduce new orthopedic technologies, with several products currently in development set to launch in the upcoming years. Targeting markets beyond Switzerland, Sevika Medical AG aims to establish a presence in additional European regions by the end of 2026. The funding from the acquisition will be allocated toward accelerating product development and enhancing market penetration strategies.